Publications » Search Results » 2010

 2020  2019  2018  2017  2016  2015  2014  2013  2012  2011  2010  2009  2008  2007  2006  2005  2004  2003  2002  2001  2000  1999  1998  1997  1996  1995  1994  1993  1992  1991  1990  1989  1988  1987  1986  1985  1984  1983  1982  1981  1980  1979  1978  1977  1976  1975  1974  1973  1972  1971  1970  1969  1968  1967  1966  1965  1964  1962  1961
Show per page  
Conferences
11Svalbe B.; Muceniece R.; Liepinsh E.; Dambrova M.; Zvejniece L. L-Carnitine regulator - mildronate exerts acute anticinvulsant and antihypnotic effects. Abstracts, 35th FEBS Congress Molecules of Life; June 25 - July 1: Gothenburg, Sweden. The FEBS Journal, Vol.277, Suppl. 1, A4.10, 2010; 79.      

12Zvejniece L.; Svalbe B.; Dambrova M. Antihypoxic action of an inhibitor of L-carnitine biosynthesis. Meeting of the COST Action TD0901 Oxygen in Health and Disease; June 15-18: Smolenice Castle, Slovakia, 2010; 65.      

13Kuka J.; Vilskersts R.; Vavers E.; Liepins E.; Dambrova M. Effects of regulation of L-carnitine concentration in experimental heart infarction model. Final Programme and Abstract Book, Frontiers in Cardiovascular Biology; First Congress of the European Society of Cardiology Council on Basic Cardiovascular Science; Berlin, 16-19 July: Cardiovascular Res., Vol.87, Suppl.1. Oxford Journals, 2010; 509.      

14Vilskersts R.; Kuka J.; Svalbe B.; Liepinsh E.; Dambrova M. Protective effects of L-carnitine and mildronate in salt-induced hypertension. Final Programme and Abstract Book, Frontiers in Cardiovascular Biology; First Congress of the European Society of Cardiology Council on Basic Cardiovascular Science; Berlin, 16-19 July: Cardiovascular Res., Vol.87, Suppl.1. Oxford Journals, 2010; 103.      

15Liepins E.; Skapare E.; Konrade I.; Dambrova M. The Effects of mildronate and metformin of energy metabolism pathways in experimental model of obesity. Abstract Volume 46th Annual Meeting, The European Association for the Study of Diabetes (EASD); 20-24 September: Stockholm, Sweden , 2010; 815.      

16Zviedre I.; Beļakovs S. Trimetilamonija dicitrātoborāta sintēze un kristāliskā struktūra. Programma, RTU 51. Starptautiskā Zinātniskā konference. Materiālzinātne un lietišķā ķīmija = RTU 51st International Scientific Conference. Materials Sciences and Applied Chemistry; 11.-15. oktobrī: Rīga, Latvija, 2010; 69.      

17Višņevska J.; Ābele E.; Šestakova I.; Jaščenko E.; Bridane V.; Kalviņš I. E-Hlorvinilsulfīdu un E-hlorvinilsulfonu katalitiskās pārvērtības un citotoksicitāte. Programma, RTU 51. Starptautiskā Zinātniskā konference. Materiālzinātne un lietišķā ķīmija = RTU 51st International Scientific Conference. Materials Sciences and Applied Chemistry; 11.-15. oktobrī: Rīga, Latvija, 2010; 69.      

18Stonkus V.; Leite L.; Edolfa K.; Fleišers M.; Krūmiņa A.; Rašmane Dz. Butilbutirāta ketonizācija Zn-Cr oksīdu katalizatora klātbūtnē. Programma, RTU 51. Starptautiskā Zinātniskā konference. Materiālzinātne un lietišķā ķīmija = RTU 51st International Scientific Conference. Materials Sciences and Applied Chemistry; 11.-15. oktobrī : Rīga, Latvija, 2010; 68.      

19Duburs G.; Klusa V.; Bisenieks E.; Poikans J.; Klimaviciusa L.; Pupure J. Recent progress with tauropyrone analogues. Joint Workshop Oxidative Stress and Neurodegenerative Diseases, COST Action D34 (Molecular Targeting in Drug Design in Neurological and Bacterial Diseases) and B35 (Lipid Peroxidation Associated Disorders) ; 15-17 January: Lisbon, Portugal, 2010; 22.      

20Della Corte L.; Tipton K.F.; Freinbichler W.; Weimberger P.; Bolea I.; Unzeta M.; Ballini C.; Kelly J.; Pilipenco J.; Duburs G.; Page M.; Lallemand F.; Colivicchi M.A.; Stefanini C.; Dexter D.T.; Ward R.J. Neuroprotection studies in in vitro models of neurodegeneration. COST Action D34 Final Meeting, Molecular Targeting in Drug Design for Neurological and Bacterial Diseases ; 13th-16th October: Firence, Convitto della Calza, Italy, 2010; 43.      

Show per page